Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for AMBBY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
March 31, 2026 7.69%
December 31, 2025 7.57%
September 30, 2025 7.84%
June 30, 2025 8.16%
March 31, 2025 12.10%
December 31, 2024 12.12%
September 30, 2024 -9.73%
June 30, 2024 9.69%
March 31, 2024 10.53%
December 31, 2023 7.34%
September 30, 2023 6.35%
June 30, 2023 4.27%
March 31, 2023 1.26%
December 31, 2022 1.94%
September 30, 2022 -11.18%
June 30, 2022 2.48%
March 31, 2022 15.60%
December 31, 2021 1.94%
September 30, 2021 -0.10%
June 30, 2021 6.37%
March 31, 2021 9.49%
December 31, 2020 8.98%
September 30, 2020 0.34%
June 30, 2020 9.71%
March 31, 2020 10.52%
Date Value
December 31, 2019 5.53%
September 30, 2019 -15.18%
June 30, 2019 27.94%
March 31, 2019 16.56%
December 31, 2018 9.60%
September 30, 2018 15.50%
June 30, 2018 16.64%
March 31, 2018 13.98%
December 31, 2017 5.06%
September 30, 2017 13.83%
June 30, 2017 13.64%
March 31, 2017 13.70%
December 31, 2016 9.38%
September 30, 2016 16.06%
June 30, 2016 14.51%
March 31, 2016 9.77%
December 31, 2015 6.71%
September 30, 2015 12.31%
June 30, 2015 4.15%
March 31, 2015 12.01%
December 31, 2014 2.06%
September 30, 2014 19.23%
June 30, 2014 8.31%
March 31, 2014 7.44%
December 31, 2013 0.88%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Coloplast A/S -13.71%
Enovis Corp. -1.43%
Edwards Lifesciences Corp. 23.09%
IDEXX Laboratories, Inc. 24.41%
Intuitive Surgical, Inc. 29.81%